CE: The science and impact of new innovations in influenza vaccines

Prior to 2019, options for influenza vaccination were limited as all products available were egg-based. Now, cell-based and recombinant vaccines are also available, and pharmacists should be knowledgeable on these options and their role in influenza prevention efforts.

This lesson will provide an overview of factors impacting influenza vaccine effectiveness, compare and contrast manufacturing processes, and summarize real-world evidence specific to the cell-based influenza vaccine.

Supported by educational funding from Seqirus, a CSL Company.

Learning objectives
 

• Define the role of neuraminidase in the immune response to influenza vaccines 
• Describe the potential impact of egg adaptation on influenza vaccine effectiveness 
• Describe the advantages and disadvantages of available technologies in influenza vaccine manufacturing 
• Apply real-world evidence on influenza vaccines to patient care

 Course author: Sherilyn Houle, BSP, PhD, CTH, AFTM RCPS (Glasg)

This continuing education is free for members of CanadianHealthcareNetwork.ca. Log in and click here to take the course: